- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0093745

Aglotus Pharmaceutical Private Limited
About Aglotus Pharmaceutical Private Limited
Data last updated:
Aglotus Pharmaceutical Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24299UP2020PTC135954. Its GSTIN is 09AAUCA1830D1ZQ (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Akanksha Srivastava and Neeti Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kh N 341 Adarsh Nagar Indira Nagar Lucknow, Uttar Pradesh, India – 226016.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.46 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹9,712 (net margin 0.9%) and EBITDA of ₹20,100 (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 152% over three years.
Aglotus Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0093745).
Company details
Recognitions & Rankings of Aglotus Pharmaceutical
Contact details
Aglotus Pharmaceutical Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressKh N 341 Adarsh Nagar Indira Nagar Lucknow, Uttar Pradesh, India – 226016
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aglotus Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aglotus Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aglotus Pharmaceutical Private Limited, buy the company report.
Financials of Aglotus Pharmaceutical Private Limited
FY 2025 filings availableAglotus Pharmaceutical Private Limited reported revenue of ₹10.46 Lakh (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 152% over three years, including 10% growth in the latest year. EBITDA rose 166% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20,100 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9,712 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aglotus Pharmaceutical Private Limited, buy the company report.
Board of directors of Aglotus Pharmaceutical Private Limited
Aglotus Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akanksha Srivastava | Director | 13 Feb 2023 | 3 Years 9 Months | Current |
| Neeti Srivastava | Director | 13 Feb 2023 | 3 Years 9 Months | Current |
| Akhil Kumar Srivastava | Director | 10 Oct 2020 | 6 Years 1 Months | Current |
Peer comparison
Aglotus Pharmaceutical Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biotree Formulations Private Limited | ₹10.55 Lakh (FY 2025) | -19.0% | Mumbai, Maharashtra, India | |||
| Cierge Formulations Private Limited | ₹10.53 Lakh (FY 2018) | -18.0% | Lucknow, Uttar Pradesh, India | |||
| Mediserve Devices Private Limited | ₹10.51 Lakh (FY 2025) | -20.0% | Delhi, India | |||
| Aglotus Pharmaceutical Private Limitedthis company | ₹10.46 Lakh (FY 2025) | ₹9,712 | 0.9% | 10.0% | Lucknow, Uttar Pradesh, India | |
| Amworld Biotech Private Limited | ₹10.3 Lakh (FY 2021) | -91.0% | Nashik, Maharashtra, India | |||
| Ani Pharma Private Limited | ₹10.3 Lakh (FY 2021) | 32.0% | Jalgaon, Maharashtra, India |
To see the full peer comparison of Aglotus Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aglotus Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aglotus Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aglotus Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAUCA1830D1ZQ | Uttar Pradesh | Active | 26 Nov 2020 |
To see the full GST registrations and return filing status of Aglotus Pharmaceutical Private Limited, buy the company report.
Recent activity
Aglotus Pharmaceutical Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Kushal Kumar Shrivastav ceased to be Director on 14 Feb 2023.
Frequently asked questions
Aglotus Pharmaceutical is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 October 2020 (6+ years old) and is registered under CIN U24299UP2020PTC135954.
Aglotus Pharmaceutical has 3 current directors:
- Akanksha Srivastava - Director
- Neeti Srivastava - Director
- Akhil Kumar Srivastava - Director
The latest financial statements of Aglotus Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Aglotus Pharmaceutical is 09AAUCA1830D1ZQ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Aglotus Pharmaceutical is U24299UP2020PTC135954. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aglotus Pharmaceutical was incorporated on 10 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Aglotus Pharmaceutical by revenue are Biotree Formulations Private Limited, Cierge Formulations Private Limited, Mediserve Devices Private Limited, Amworld Biotech Private Limited, Ani Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Kushal Kumar Shrivastav ceased to be Director on 14 Feb 2023. Akanksha Srivastava was appointed as Director on 13 Feb 2023. Neeti Srivastava was appointed as Director on 13 Feb 2023. Aglotus Pharmaceutical has 4 board changes on record in total.
Yes, Aglotus Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0093745).
The registered office of Aglotus Pharmaceutical is at Kh N 341 Adarsh Nagar Indira Nagar Lucknow, Uttar Pradesh, India – 226016.
Aglotus Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.

